Title 50 › CHAPTER 46 — CENTRAL INTELLIGENCE AGENCY › § 3529
The Director must create a nine-member medical advisory board inside the Agency. The board must study the Agency’s Office of Medical Services and give advice. It will work to modernize the Office, make sure its work is high quality, and make sure medical care follows top professional standards. The board must send interim and a final written report to the congressional intelligence committees. The final report must explain the board’s findings, give recommendations for changes, and include any member’s dissenting views. Nine people will be appointed by leaders in the House, Senate, the congressional intelligence committees, and the Director of National Intelligence. At the first meeting the members will elect a chair who cannot be a current or former Agency employee. Each member must be a recognized medical expert with clinical experience and able to get a security clearance. Members serve for the life of the board; vacancies are filled the same way they were appointed. Members may be paid up to the daily equivalent of Executive Schedule level IV when working, federal employees get no extra pay, and travel costs follow section 5703 of title 5. The DNI may assign staff with clearances to help the board. The board must meet at least quarterly and meet the congressional intelligence committees twice a year. It can get information from any federal agency unless the Director, personally, denies a request; if denied, the Director must tell the congressional intelligence committees in writing within 15 days. The Director must also make sure the board gets full briefings on the Office of Medical Services when requested. The board ends five years after its first meeting. The terms “congressional intelligence committees” and “intelligence community” have the meanings given in section 3003.
Full Legal Text
War and National Defense, Source: USLM XML via OLRC
Legislative History
Reference
Citation
50 U.S.C. § 3529
Title 50, War and National Defense
Last Updated
Sep 22, 2026
Release point: 119-110